Fingerprint
Dive into the research topics of 'Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Mahran Shoukier, Jamani Garner, K. M. Islam, Jorge E. Cortes
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations